The Key Role of NIH in SEEDing the Product Development Pipeline
NIH recently created the SEED Office to accelerate NIH-funded biomedical innovations from bench to bedside. SEED supports a comprehensive translational research ecosystem that includes a nation-wide network of academic proof-of-concept centers and a small business program that invests over $1 billion annually in a portfolio of more than 1500 life science companies. SEED also provides technical and entrepreneurial advisory services and builds relationships with business, finance, and healthcare stakeholders to ensure these innovations will impact patients’ lives. This panel will highlight NIH’s strategic focus in early product development, resources and opportunities available to academic and small business innovators, and the ways strategic partners and investors can partner with NIH to access novel technologies.